← Back
$KALV All transactions

KalVista Pharmaceuticals, Inc.

M

$ Value

$0

Shares

5,000

Price

$0

Filed

Aug 26

Insider

Name

Sweeny Nicole

Title

Chief Commercial Officer

CIK

0001827505

Roles

Officer

Transaction Details

Transaction Date

2025-08-22

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

55,000

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. | 1/16th of the total number of shares underlying the RSUs shall vest on each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as grantee's Service (as defined in the Plan) does not terminate.

Filing Info

Accession No.

0001415889-25-023075

Form Type

4

Issuer CIK

0001348911

Sweeny Nicole's History

Date Ticker Type Value
2026-04-16 KALV M
2026-04-16 KALV M $0
2025-11-24 KALV $51K
2025-11-22 KALV M
2025-11-22 KALV M $0
2025-11-21 KALV M
2025-11-21 KALV M $0
2025-08-25 KALV $20K
2025-08-22 KALV $25K
2025-08-22 KALV M

Other Insiders at KALV (90d)

Insider Bought Sold Last
Palleiko Benjamin L
CHIEF EXECUTIVE OFFICER
$193K 2026-04-17
Venrock Healthcare Capital Partners III, L.P. $3.7M 2026-03-26
Piekos Brian
Chief Financial Officer
2026-04-16
Piekos Brian / Sweeny Nicole
Chief Financial Officer
$38K 2026-04-17
Sweeny Nicole
Chief Commercial Officer
2026-04-16
Audhya Paul K.
CHIEF MEDICAL OFFICER
$54K 2026-04-17